PARK INNOVAARE

Upcoming events

Thursday
30.11.2017
PARK INNOVAARE

Info-Event: Technologieprojekte finanzieren mit KMU-Instrument und Fast Trak to Innovation (FTI)

KMU Instrument info-event

Ob Unternehmen mit Innovationen erfolgreich sind, hängt in hohem Masse vom Zugang zu den erforderlichen Finanzmitteln ab. Art und Anzahl der zur Verfügung stehenden Finanzierungsinstrumente in wissenschaftsnahen bzw. technologieorientierten Branchen sind vielfältig. Um Ihnen einen Überblick zu geben, lädt PARK INNOVAARE Sie zu unserem vierteljährlichen Info-Event ein.


(This information is only available in German.)

Besonders interessant sind dabei solche Geldquellen, die direkt den Unternehmen zugutekommen und nicht zur Verwässerung der eigenen Unternehmensanteile führen (also „non-dillutive“ sind) bzw. einen nicht-monetären Zusatznutzen aufweisen, der erheblich sein kann. Solche Instrumente und Wege gibt es, und wir stellen Sie Ihnen vor:

  • KMU-Instrument und Fast Track to Innovation (FTI)​​​​​​​: Die Schweiz hat seit Anfang 2017 Zugang zu zwei Finanzierungsinstrumenten innerhalb des EU-Programms Horizon 2020, dem KMU-Instrument und dem FTI. Mit dem KMU-Instrument können einzelne KMUs sich ohne Beteiligung wissenschaftlicher Partner um bis zu 2.5 Mio EUR direkter Projektfinanzierung bewerben. Der FTI stellt kleinen Konsortien von KMUs bzw. Grossunternehmen auch mit Beteiligung von wissenschaftlichen Partnern bis zu 3 Mio. EUR zur Verfügung.
  • Bundesbürgschaft (Switzerland Innovation): Der PARK INNOVAARE verfügt ab Januar 2018 mit der sog. Bundesbürgschaft über ein proprietäres Instrument der Finanzierungsunterstützung, mit dem Technologieunternehmen jeder Grösse deutlich verbilligte Bankkredite erhalten können.
  • Business Angel Club Aargau: Der Kanton Aargau pflegt vielfältige Kontakte zu Business Angels und baut diese mit dem in Gründung befindlichen „Business Angel Club Aargau“ aus. Welchen Nutzen hat dieses Netzwerk für Gründer und Start ups und wie findet man als Gründer den richtigen Business Angel?

Gemeinsam mit der m27 aus Wien, Spezialisten in der Förderberatung für EU-Mittel, sowie der aargauischen Standortförderung Aargau Services informieren wir über die über Chancen und Zugangswege zu den genannten Instrumenten.


Agenda

10:00 - 10:15   Warm-up & Coffee

10:15 - 10:30   PARK INNOVAARE: Die Bundesbürgschaft von Switzerland Innovation; Sprecher: Nils Gebhardt, innovAARE AG

10:30 - 11:15   Neu im Kanton Aargau: “Business Angel Club Aargau“; Sprecher: Florian Gautschi, Aargau Services Standortförderung

11:15 - 12:00   KMU-Instrument (EU/Horizon 2020); Sprecher: Javier Calvet-Stoffel, M27 und Silvia Meléndez, Inspiralia

12:00 - 12:30   Pause

12:30 - 15:00   Pre-Evaluation KMU-Instrument (1:1 Sessions)


Exklusives Service-Angebot für KMU:

Im Anschluss an die Veranstaltung können sich technologieorientierte KMU und Start-ups bzw. Spin-offs von wissenschaftlichen Institutionen, die kurz vor der Gründung stehen, in 1:1-Sessions mit den Spezialisten von m27 eine Vor-Evaluation für das KMU-Instrument durchführen (Anmeldung erforderlich). Dabei wird geprüft, ob für den nächsten Stichtag eine Bewerbung erfolgreich umgesetzt werden kann.


Sprache / Language

The event will take place in German or Enlish (upon participants request)

Speakers

Time

10:00-12:30 (mit 1:1-Sessions bis ca. 15 Uhr)

Location

PARK INNOVAARE: deliveryLAB

Downloads

Accreditation

Die Teilnahme ist kostenlos. Anmeldungen bitte telefonisch unter Tel. +41 56 461 70 70 oder an Dr. Francesco Colonna (colonna@parkinnovaare.ch). Wir freuen uns auf Ihre Teilnahme.

* Mandatory fields / Pflichtangaben

Gender *

First name *

Last name *

Company

Job title

Email adress *

Comment


Tuesday
05.12.2017
External Event

Drug Discovery made in Switzerland: info event in Shanghai

Drug Discovery made in Switzerland

Based on an innovative strategic partnership agreed between the Chinese President and the President of the Swiss Confederation in 2016, SWITZERLAND INNOVATION cordially invites you to the Drug Discovery Event at the Novartis Campus in Shanghai.


About the Event:

Drug discovery has come a long way from guess work to a structural and targeted approach to finding new and better remedies. In order to see the big picture and to develop new drugs, companies need to stay up to date about the latest discoveries in genomics, proteomics, structural or quantitative biology. The industry must translate the scientific efforts into a new innovative product.

At SWITZERLAND INNOVATION, such interdisciplinary collaborations between science and industry can flourish, thus finding keys and  pathways to more precise medicine and bring drug discovery into a new era. Together with the Swiss Business Hub China, SWITZERLAND INNOVATION is committed to promote Switzerland as a location for R&D and innovation. International corporations such as Roche, Novartis, and Actelion (J&J), have their home base and global research centers in Switzerland. Other leading biotech and pharmaceutical companies — many of them from the US — including AC Immune, Alnylam, Amgen, Biogen, Bluebird, Fosun, Luye Pharma, Prothena, or Tesaro have chosen Switzerland as an R&D location. Together with Novartis and Roche as the incumbent players, they attract many highly skilled experts from all over the world.


 Program Rundown:
14.00 – 14.30   Registration
14.30 – 15.30   Key note speaches: Prof. Christoph Hock and Prof. Michael Hennig
15.30 – 16.30   Panel Discussion
16.30 – 18.00   Networking


 

Speakers

Professor Christoph Hock, MD

  • Co-director of the Institute of Regenerative Medicine (IREM) at the University of Zurich
  • Clinician and clinical trialsinvestigator
  • Vice President for Medicine at University of Zurich

Prof. Hock is the co-founder and board member of  Neurimmune. The biopharmaceutical company partnered its lead program in Alzheimer’s disease with Biogen in 2007 and developed a recombinant human monoclonal antibody targeting the neurodegenerative process in Alzheimer’s disease.

Professor Michael Hennig, PhD

  • 20 years of drug discovery expertise from research management at F. Hoffmann – La Roche AG Basel.
  • Guest Professor for structural biology at the University of Basel
  • Structural biologist and senior Pharma drug discovery executive
  • Entrepreneur, co-founder of leadXpro AG

Prof. Hennig is CEO and Chairman of the Board of the biotech company leadXpro AG, located at the Switzerland Innovation Park innovaare. The company is committed to structure and biophysical methods based drug discovery on membrane protein targets. Key areas of research include the use of large research facilities such as Swiss Light Source (SLS),  Swiss Free Electron Laser (SwissFEL) and single particle cryo-electron microscopy (cryo-EM). leadXpro’s research activities are focused on the lead discovery for better cancer treatments and antibiotics with new mechanisms of action.

Time

14.30-17.30

Location

诺华集团 上海市浦东新区金科路 4218 号 Novartis Campus Shanghai, Jinke Road 4218, Pudong

Downloads

Wednesday
24.01.2018
PARK INNOVAARE

INNOVATION in PRACTICE | Special

Intellectual property management

INTELLECTUAL PROPERTY (IP) MANAGEMENT

Intellectual property (IP) is as indispensable for a company’s success as innovation itself. Proper IP management can significantly improve a company’s position on the market, help it stand out from its competitors and increase its value. IP management is particularly important at the interface between science and industrial research, where progress often depends on technology transfer. To help you optimize your IP management and discuss best practices, we invite you to join our half-day workshop dedicated to this highly relevant subject.

 


Workshop topics

Our workshop participants will become acquainted with the general framework and success factors for efficient IP management. Presentations will feature practical examples from the industry that are as interesting as they are diverse. In “break-out” sessions, participants will be able to contribute their own questions to the dialogue. The workshop will conclude with practical tips on how to review and pragmatically (continue to) develop one’s own IP strategy.

  • Global trends in IP Management
  • Value generation through IP management
  • Basic terms and safeguards
  • Implementation of property rights in other countries, dealing with disputes
  • Evaluation of technologies and patents
  • Patent strategy and patent management
  • IP management in R&D collaborations
  • Licensing and exploitation
  • Patent portfolio management, internal policies
  • Cost optimization, handling of a few legally protected patents
  • Weaknesses and practical measures to overcome them
  • Instruments against piracy and counterfeiting
  • IP management and patent protection in an international context

Workshop agenda

8:00 am                   Arrival 

8.15 am                   Welcome remarks

8:20 am                   Introduction: Importance of IP Management

8:40 am                   Legal basics 

9:10 am                   IP Management in practice: Formation and evaluation of IP

Break

9:45 am                   Company's example 1 

10:15 am                 IP Management in practice: Practical implementation of IP

11:15 am                 Company's example 2

11:45 am                 Discussion in "break-out" sessions

Snak break

12:30 pm                Q&A session and discussion

12:50 pm                Conclusions & Take aways


Speakers

Axel Stellbrink

Axel Stellbrink

Axel Stellbrink is the founder and managing director of Patentanwaltskanzlei Stellbrink & Partner, a firm specializing in patent law. For more than 25 years, he has been advising companies, universities and institutions on the subject of industrial property rights in Europe, the USA, Israel, China, Japan and Korea.

Dr. Markus Fiechter

Dr. Markus Fiechter

Dr. Markus Fiechter, LL.M., is a lawyer and a partner at VOSER AG dealing with business law and intellectual property law. He advises start-up ventures and established firms in these areas.

Andrea Foglia

Andrea Foglia

Andrea Foglia, a Technology Transfer Manager at the Paul Scherrer Institute (PSI), advises scientists and researchers in the areas of intellectual property, cooperation with the industry, commercialization, law and licensing.

Time

8:00 - 13:00

Location

PARK INNOVAARE: deliveryLAB

Downloads

Accreditation

The participation fee is 50 CHF (plus VAT) per person. For PARK INNOVAARE partners, shareholders and resident companies the event is free of charge. The number of participants is limited. Please write us at anmeldung@parkinnovaare.ch or fill out the form below to register.

* Mandatory fields / Pflichtangaben

Gender *

First name *

Last name *

Company

Job title

Email adress *

Comment


event archive